Benzbromarone

This classification denotes a uricosuric agent with the molecular formula C17H12Br2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4POG0RL69O, chemically known as 3,5-dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone but generally known as benzbromarone, which bears US NIH Compound Identifier 2333. European Medicines Agency schedules Benzbromarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05743MIG. The term BENZBROMARONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules benzbromarone in its Anatomical Therapeutic Chemical (ATC) Classification. BENZBROMARONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzbromarone under HS 29329985 and SITC 51569. As of Q4 2014, BENZBROMARONE remains the US FDA Preferred Term for this commodity. Benzbromarone bears US NLM identifiers UMLS ID C0005035 and NCI Concept Code C74412. SMILES: BRC1CC(C(=O)C2C3C(OC2CC)CCCC3)CC(BR)C1O.